173841-06-0

Basic information

• Product Name: Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate
• Synonyms: Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate
• CAS NO: 173841-06-0
• Molecular Formula: C₆H₇ClN₂O₂
• Molecular Weight: 174.58498
• Mol File: 173841-06-0.mol

Chemical Properties

• Melting Point: 23-25 °C
• Boiling Point: 259.3±20.0 °C(Predicted)
• Appearance: /
• Density: 1.37±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -2.04±0.10(Predicted)
• CAS DataBase Reference: Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate(173841-06-0)
• EPA Substance Registry System: Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate(173841-06-0)

Safety Data

• Hazardous Substances Data: 173841-06-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate is utilized as an intermediate in the production of various pharmaceuticals. Its specific structural attributes and reactivity make it a key component in the synthesis process, contributing to the development of new medications.
Used in Agrochemical Production:
In the agrochemical industry, Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate serves as an essential intermediate. Its role in the synthesis of agrochemicals is crucial for creating effective products used in agriculture to protect crops and enhance yields.
Used as a Building Block in Organic Synthesis:
Beyond its applications in pharmaceuticals and agrochemicals, Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate also functions as a versatile building block in organic synthesis. It is employed to construct a wide array of other compounds, expanding its utility across various chemical domains.
Used in Medicinal Chemistry and Drug Development:
Due to its structural features and reactivity, Methyl 3-chloro-1-Methyl-1H-pyrazole-5-carboxylate holds promise in the field of medicinal chemistry. It is explored for its potential to contribute to the discovery and development of new drugs, enhancing treatment options for various medical conditions.

Upstream product

• 762-42-5 dimethyl acetylenedicarboxylate 
• 52867-42-2 5-hydroxy-2-methyl-2H-pyrazole-3-carboxylic acid methyl ester 
• 1312949-20-4 methyl 3-chloro-1-methyl-4,5-dihydro-1H-pyrazole-5-carboxylate 
• 1312949-19-1 methyl 3-hydroxy-1-methyl-4,5-dihydro-1H-pyrazole-5-carboxylate 
• 624-49-7 dimethylfumarate 

Relevant articles and documents

Sulfamide-aryl amide type compound and medical application thereof in treatment of hepatitis B

The invention relates to a sulfamide-aryl amide type compound and the medical application thereof in treatment of hepatitis B, and specifically discloses a compound which can be treated as an HBV compound inhibitor and has the structure as shown in chemical formula (A), or a stereisomer, a cis-trans-isomer or a tautomer thereof, or pharmaceutically acceptable salt, aquo-complex or solvent compoundthereof; the identification of each group is shown in the description. The invention also relates to a medical composition containing the abovementioned compound and application thereof in treatmentof hepatitis B.

Compound for treatment on hepatitis B and use thereof

The invention relates to a compound for treatment on hepatitis B and a use thereof. Specifically, the invention discloses a compound as a HBV replication inhibitor having the structure shown in the formula (A), or its stereoisomer, tautomer, pharmaceutically acceptable salt, hydrate or solvate. The groups are detailed in the specification. The invention also relates a pharmaceutical composition containing the compound and a use thereof in treatment on hepatitis B.

DISUBSTITUTED HETEROARYL-FUSED PYRIDINES

The invention relates to compound of the formula (I′) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

DISUBSTITUTED HETEROARYL-FUSED PYRIDINES

The invention relates to compound of the formula (I') in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.